{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:57:02Z","timestamp":1767211022268,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T00:00:00Z","timestamp":1494979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Japan Society for Patients-Reported Outcome research fund","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s13300-017-0267-2","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T04:22:40Z","timestamp":1494994960000},"page":"693-704","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis"],"prefix":"10.1007","volume":"8","author":[{"name":"SPIKE Trial Site Investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4401-2965","authenticated-orcid":false,"given":"Tomoya","family":"Mita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Katakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Shiraiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Yoshii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Gosho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Watada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,17]]},"reference":[{"key":"267_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.diabres.2008.03.020","volume":"81","author":"H Ishii","year":"2008","unstructured":"Ishii H, Anderson JH Jr, Yamamura A, Takeuchi M, Ikeda I. Improvement of glycemic control and quality-of-life by insulin lispro therapy: assessing benefits by ITR-QOL questionnaires. Diabetes Res Clin Pract. 2008;81:169\u201378.","journal-title":"Diabetes Res Clin Pract"},{"key":"267_CR2","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1001\/archinte.166.17.1836","volume":"166","author":"PM Ho","year":"2006","unstructured":"Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836\u201341.","journal-title":"Arch Intern Med"},{"key":"267_CR3","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.2337\/dc17-S011","volume":"40","author":"American Diabetes Association","year":"2017","unstructured":"American Diabetes Association. 8. Pharmacologic approaches to glycemic treatment. Diabetes Care. 2017;40:S64\u201374.","journal-title":"Diabetes Care"},{"key":"267_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/dmrr.865","volume":"24","author":"RJ Wright","year":"2008","unstructured":"Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev. 2008;24:353\u201363.","journal-title":"Diabetes Metab Res Rev"},{"key":"267_CR5","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.2337\/diacare.25.10.1691","volume":"25","author":"SM Strowig","year":"2002","unstructured":"Strowig SM, Aviles-Santa ML, Raskin P. Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes. Diabetes Care. 2002;25:1691\u20138.","journal-title":"Diabetes Care"},{"key":"267_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00592-010-0206-4","volume":"48","author":"M Nemoto","year":"2011","unstructured":"Nemoto M, Tajima N, Kawamori R. Efficacy of combined use of miglitol in type 2 diabetes patients receiving insulin therapy-placebo-controlled double-blind comparative study. Acta Diabetol. 2011;48:15\u201320.","journal-title":"Acta Diabetol"},{"key":"267_CR7","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1463-1326.2006.00622.x","volume":"9","author":"AN Jacob","year":"2007","unstructured":"Jacob AN, Salinas K, Adams-Huet B, Raskin P. Weight gain in type 2 diabetes mellitus. Diabetes Obes Metab. 2007;9:386\u201393.","journal-title":"Diabetes Obes Metab"},{"key":"267_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1507\/endocrj.52.563","volume":"52","author":"H Ose","year":"2005","unstructured":"Ose H, Fukui M, Kitagawa Y, et al. Efficacy of glimepiride in patients with poorly controlled insulin-treated type 2 diabetes mellitus. Endocr J. 2005;52:563\u20139.","journal-title":"Endocr J"},{"key":"267_CR9","first-page":"759","volume":"73","author":"I Ahmed","year":"2006","unstructured":"Ahmed I, Goldstein BJ. Cardiovascular risk in the spectrum of type 2 diabetes mellitus. Mt Sinai J Med N Y. 2006;73:759\u201368.","journal-title":"Mt Sinai J Med N Y"},{"key":"267_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1507\/endocrj.EJ12-0293","volume":"60","author":"T Katsuno","year":"2013","unstructured":"Katsuno T, Ikeda H, Ida K, Miyagawa J, Namba M. Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus. Endocr J. 2013;60:733\u201342.","journal-title":"Endocr J"},{"key":"267_CR11","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1507\/endocrj.EJ13-0198","volume":"60","author":"S Shimoda","year":"2013","unstructured":"Shimoda S, Iwashita S, Ichimori S, et al. Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy. Endocr J. 2013;60:1207\u201314.","journal-title":"Endocr J"},{"key":"267_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1475-2840-12-35","volume":"12","author":"Y Sakamoto","year":"2013","unstructured":"Sakamoto Y, Oyama J, Ikeda H, et al. Effects of sitagliptin beyond glycemic control: focus on quality of life. Cardiovasc Diabetol. 2013;12:35.","journal-title":"Cardiovasc Diabetol"},{"key":"267_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2337\/dc15-2145","volume":"39","author":"T Mita","year":"2016","unstructured":"Mita T, Katakami N, Shiraiwa T, et al. Sitagliptin attenuates the progression of carotid intima-media thickening in insulin-treated patients with type 2 diabetes: the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): a randomized controlled trial. Diabetes Care. 2016;39:455.","journal-title":"Diabetes Care"},{"key":"267_CR14","doi-asserted-by":"publisher","first-page":"e0121988","DOI":"10.1371\/journal.pone.0121988","volume":"10","author":"S Sato","year":"2015","unstructured":"Sato S, Saisho Y, Kou K, et al. Efficacy and safety of sitagliptin added to insulin in Japanese patients with type 2 diabetes: the EDIT randomized trial. PLoS One. 2015;10:e0121988.","journal-title":"PLoS One"},{"key":"267_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1758-5996-6-35","volume":"6","author":"T Mita","year":"2014","unstructured":"Mita T, Katakami N, Shiraiwa T, et al. Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE). Diabetol Metab Syndr. 2014;6:35.","journal-title":"Diabetol Metab Syndr"},{"key":"267_CR16","unstructured":"Japan Diabetes Society. Araki E, Iwamoto Y, Kadowaki T, Kashiwagi A, Kitaoka M, Nanjo K, Tajima N, editors. Treatment guide for diabetes. Tokyo: Bunkodo; 2010."},{"key":"267_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3111\/13696998.2012.665111","volume":"15","author":"H Ishii","year":"2012","unstructured":"Ishii H. Development and psychometric validation of the Diabetes Therapy-Related QOL (DTR-QOL) questionnaire. J Med Econ. 2012;15:556\u201363.","journal-title":"J Med Econ"},{"key":"267_CR18","volume-title":"Psychometric theory","author":"JC Nunnally","year":"1978","unstructured":"Nunnally JC. Psychometric theory. 2nd ed. New York: McGraw-Hill; 1978.","edition":"2"},{"key":"267_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2337\/dc08-0856","volume":"32","author":"RT Anderson","year":"2009","unstructured":"Anderson RT, Girman CJ, Pawaskar MD, et al. Diabetes medication satisfaction tool: a focus on treatment regimens. Diabetes Care. 2009;32:51\u20133.","journal-title":"Diabetes Care"},{"key":"267_CR20","first-page":"215","volume":"63","author":"N Kleefstra","year":"2005","unstructured":"Kleefstra N, Ubink-Veltmaat LJ, Houweling ST, Groenier KH, Meyboom-de Jong B, Bilo HJ. Cross-sectional relationship between glycaemic control, hyperglycaemic symptoms and quality of life in type 2 diabetes (ZODIAC-2). Neth J Med. 2005;63:215\u201321.","journal-title":"Neth J Med"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-017-0267-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13300-017-0267-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-017-0267-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T15:49:12Z","timestamp":1548085752000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13300-017-0267-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,17]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["267"],"URL":"https:\/\/doi.org\/10.1007\/s13300-017-0267-2","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"type":"print","value":"1869-6953"},{"type":"electronic","value":"1869-6961"}],"subject":[],"published":{"date-parts":[[2017,5,17]]},"assertion":[{"value":"22 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2017","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}